Cassava Sciences | PTIE - Market Capitalization


Cassava Sciences reported $60.5M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cassava Sciences USD 96M 45M Dec/2025
Eisai JPY 1.42T 110.62B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Geron USD 955M 112M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 153.81B 12.24B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025